provider image
Welcome! You’re in GoodRx for healthcare professionals. Now, you’ll enjoy a streamlined experience created specifically for healthcare professionals.
Skip to main content
HomeDrugsRobaxin

Popular Muscle Relaxer Robaxin Recalled Due to Incorrect Dosing Instructions

Ronilee Shye, PharmD, BCGP, BCACP, CDE
Published on October 1, 2018
This article is no longer being updated and some information may not be current. Visit the GoodRx Health homepage for our latest articles.

Two lots of Robaxin (methocarbamol), a popular prescription muscle relaxer, were voluntarily recalled due to faulty dosing information on the label. Following these incorrect instructions could potentially lead to serious side effects and fatal overdose.

FDA Recall red seal on a light red background.
GoodRx Health

What is Robaxin?

Robaxin is a popular muscle relaxer. It contains methocarbamol, which is used to treat painful muscle spasms alongside other treatment methods like rest and physical therapy.

Why was Robaxin recalled?

Select lots of Robaxin were voluntarily recalled by manufacturer Endo Pharmaceuticals due to incorrect daily dosing information on the label. The label instructs patients to take “two to four tablets daily,” instead of the correct dosage of “two tablets three times daily.”

Taking too much methocarbamol can result in drowsiness, dizziness and an increased risk for falls. More serious adverse effects of a methocarbamol overdose may include seizure, coma, and even death.

Which products were recalled?

This recall affects only the following two lots of Robaxin:

  • Drug: Robaxin 750 mg tablets

  • Bottle size: 100 count bottle pack

  • Manufacturer: Endo Pharmaceuticals

  • Lots:

    • 216702P1, expiration date: September 2020

    • 220409P1, expiration date: January 2021

  • National Drug Code (NDC): 52244-0449-10

To find out if your Robaxin prescription was affected by this recall, look for the lot number and expiration date on your bottle label. We created some diagrams here in case you need more help locating these numbers.

What should I do if I think I have a recalled product?

1) Stop taking it and return any unused product

Endo Pharmaceuticals Inc. is arranging for the return of all recalled products through Inmar, Inc. Consumers who have a recalled product should discontinue use and return any unused product to Inmar by following these instructions:

Call Inmar at 1-866-391-0620, Monday through Friday (9AM to 5PM EST) or email robaxin@inmar.com to return your product and receive a reimbursement for your purchase. Upon contacting Inmar, you will receive shipping instructions and labels to return your unused product. If you request a reimbursement, you will need to share your proof of purchase.

Proof of purchase can be sent to robaxin@inmar.com or 635 Vine St. Winston Salem, Attention: Recall Department, Robaxin Recall, NC 27101.

2) Contact the manufacturer with any questions

If you have any questions about this recall, you can contact Inmar at 1-866-391-0620 Monday through Friday from 9am to 5pm EST or by email at robaxin@inmar.com.

3) Talk to your doctor or pharmacist

If you need a replacement for your Robaxin product or have any health concerns that you think might be related to this recall, contact your healthcare provider. Several other pharmaceutical companies make methocarbamol 750 mg tablets, so there are replacement options.

– – –

When you bring home any new medication, always inspect it, including all parts of the packaging. If you ever notice your medication doesn’t look or smell right, contact the manufacturer or ask your pharmacist for more information. Any adverse reactions or quality problems can also be reported to the FDA’s MedWatch Reporting Program.

why trust our exports reliability shield

Why trust our experts?

Ronilee Shye, PharmD, BCGP, BCACP, CDE
Roni is an expert in clinical pharmacy and patient care. She received her doctorate in pharmacy from Duquesne University in Pittsburgh, Pennsylvania; is board-certified in geriatrics and ambulatory care pharmacy; and is licensed to practice pharmacy in Ohio, Pennsylvania, and Florida.
Benita Lee, MPH
Edited by:
Benita Lee, MPH
Benita Lee, MPH, is director of content and operations at GoodRx and contributes to content strategy and process management across editorial and product initiatives. She is passionate about building collaborative teams and has a deep interest in using research to improve health outcomes in innovative and sustainable ways.

Was this page helpful?

Subscribe and save.

Get prescription saving tips and more from GoodRx Health. Enter your email to sign up.

By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.

Browse medications

View All

Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.